Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
N02BB04
CAS registry number (Chemical Abstracts Service)
0000479-92-5
Chemical Formula
C14-H18-N2-O
Molecular Weight
230
Therapeutic Categories
Analgesic, antipyretic and anti-inflammatory agent
Non-steroidal anti-inflammatory drug, NSAID
Chemical Name
3H-Pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-(1-methylethyl)-2-phenyl-
Foreign Names
- Propyphenazonum (Latin)
- Propyphenazon (German)
- Propyphénazone (French)
- Propifenazona (Spanish)
Generic Names
- Isopropylantipyrine (OS: JAN)
- Propifenazone (OS: DCIT)
- Propyphenazone (OS: BAN)
- Propyphénazone (OS: DCF)
- Isopropylphenazonum (IS)
- Isopropylantipyrine (PH: JP XIV)
- Propyphenazon (PH: Ph. Eur. 6)
- Propyphenazone (PH: BP 2010, Ph. Eur. 6)
- Propyphénazone (PH: Ph. Eur. 6)
- Propyphenazonum (PH: Ph. Eur. 6)
Brand Names
- Cibalgin
Novartis, Bahrain; Novartis, Ghana; Novartis, Kenya; Novartis, Libya; Novartis, Nigeria; Novartis, Sudan; Novartis, Tanzania; Novartis, Zimbabwe - Cistalgan (Propyphenazone and Flavoxate)
Rottapharm, Italy - Daro Hoofdpijnpoeder (Propyphenazone and Paracetamol)
Heca, Netherlands - Demex
Berlin-Chemie, Germany - Enkapyrin (Propyphenazone and Phenylbutazone)
Kimia Farma, Indonesia - Optalidon (Propyphenazone and Caffeine)
Novartis Consumer Health, Spain - Para-don (Propyphenazone and Paracetamol)
Etos, Netherlands; Healthypharm, Netherlands - Propifenazona
Arena, Romania - Propifenazone
AFOM, Italy - Sanalgin (Propyphenazone and Paracetamol)
Alfaco, Netherlands - Saridon (Propyphenazone and Paracetamol)
Bayer, Austria; Bayer, Netherlands - Spasmo Cibalgin
Novartis, Oman
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment